BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15194999)

  • 1. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience.
    Ronga G; Filesi M; Montesano T; Di Nicola AD; Pace C; Travascio L; Ventroni G; Antonaci A; Vestri AR
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):12-9. PubMed ID: 15194999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
    Zaydfudim V; Feurer ID; Griffin MR; Phay JE
    Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics.
    Okada T; Sasaki F; Takahashi H; Taguchi K; Takahashi M; Watanabe K; Itoh T; Ota S; Todo S
    Eur J Pediatr Surg; 2006 Feb; 16(1):8-13. PubMed ID: 16544219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
    Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
    Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
    Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
    Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
    Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
    Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
    Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.
    Casara D; Rubello D; Saladini G; Masarotto G; Favero A; Girelli ME; Busnardo B
    J Nucl Med; 1993 Oct; 34(10):1626-31. PubMed ID: 8410272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.